CPHI to Hold Third Quarter 2018 Earnings Conference Call On Thursday, November 15, 2018 at 8:30 a.m. ET

HAIKOU,China,Nov.12,2018 -- China Pharma Holdings,Inc. ("China Pharma") (NYSE MKT: CPHI),an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China,today announced that it plans to hold its third quarter 2018 earnings conference call on Thursday,November 15,2018 at 8:30 a.m. ET.

Listeners may access the call by dialing 1-866-519-4004 or 65-671-350-90 for international callers,Conference ID# 4389333. A replay of the call will be accessible through November 23,2018 by dialing 1-855-452-5696 or 61-281-990-299 for international callers,Conference ID # 4389333.

About China Pharma Holdings,Inc.

China Pharma Holdings,Inc. is a specialty pharmaceutical company that develops,manufactures and markets a diversified portfolio of products focused on conditions with a high incidence and high mortality rates in China,including cardiovascular,CNS,infectious,and digestive diseases. The Company's cost-effective business model is driven by market demand and supported by new GMP-certified product lines covering the major dosage forms. In addition,the Company has a broad and expanding nationwide distribution network across all major cities and provinces in China. The Company's wholly-owned subsidiary,Hainan Helpson Medical & Biotechnology Co.,Ltd.,is located in Haikou City,Hainan Province. For more information about China Pharma Holdings,Inc.,please visit http://www.chinapharmaholdings.com. The Company routinely posts important information on its website.

View original content:/news-releases/cphi-to-hold-third-quarter-2018-earnings-conference-call-on-thursday-november-15-2018-at-830-am-et-300748134.html